By requiring health benefit plans to cover Lyme disease treatment, Bill S926 is poised to significantly influence state healthcare laws. It enforces a mandate on insurers to cover costs associated with this particular condition, aligning with the growing recognition of Lyme disease as a serious health issue. The bill ensures that individuals, especially those in high-risk areas, can obtain adequate medical attention without facing financial hurdles. This aligns state regulations with a more patient-centered approach to healthcare.
Summary
Bill S926, proposed in New Jersey, mandates that health insurers provide coverage for the treatment of Lyme disease. The bill outlines that all insurance contracts, including those from hospital service corporations and health maintenance organizations, must cover expenses deemed medically necessary by a physician. This legislative measure is aimed at ensuring that individuals diagnosed with Lyme disease can access the necessary treatment without the threat of denial based on the treatment being classified as experimental or investigational.
Contention
Despite its supportive intent, the bill may generate discussions regarding its implications for insurance companies and their operational frameworks. Concerns may arise about potential increases in premiums or a pushback from insurers regarding what constitutes medically necessary treatment. Legislative debates could center on the balance between ensuring patient access to necessary treatments while managing the financial viability of health insurance providers.
Providing for patient access to diagnostics and treatments for Lyme disease and related tick-borne illnesses; and requiring health care policies to provide certain coverage.
Requires health insurers to provide coverage for long term medical care for Lyme disease and other tick borne related pathogens; provides for taxpayer gifts for tick borne illness research, detection and education; establishes the tick borne illness research, detection and education fund.
A bill for an act establishing a veterans recovery pilot program and fund for the reimbursement of expenses related to providing hyperbaric oxygen treatment to eligible veterans and making appropriations.(Formerly HF 326.)
A bill for an act establishing a veterans recovery pilot program and fund for the reimbursement of expenses related to providing hyperbaric oxygen treatment to eligible veterans and making appropriations.(See HF 518.)